← Back
Data updated: Mar 10, 2026
CENTAUR PHARMS PVT
OncologyInfectious DiseaseNeurology
CENTAUR PHARMS PVT is a generic drug manufacturer focused on Oncology, Infectious Disease, Neurology.
2026
Since
1
Drugs
-
Trials
15
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 42%
0 drugs Phase 3: 3 Phase 1: 2
Infectious Disease 24%
0 drugs Phase 3: 1 Phase 2: 2
Neurology 18%
1 drugs
Dermatology 15%
0 drugs Phase 3: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2026-02-23
- Latest
- 2026-02-23
- Applications
- 1